About
Technology
Issues
FAQ
Links
Official Page
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.